Jefferies Group’s Vivani Medical VANI Stock Holding History

Jefferies Group’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,042	Closed	-$121K	–	2459
2016 Q1	$121K	Buy	+1,042	New	+$120K	﹤0.01%	1942

Other funds holding VANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VDBMI

Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jefferies Group's VANI Position: Q2 2016 in Review

Jefferies Group sold out of Vivani Medical (VANI) in Q2 2016, closing a stake of 1,042 shares — an estimated $121K sold.

Jefferies Group first reported a position in VANI in Q1 2016 and held it in 1 quarter. The position peaked at $121K in Q1 2016. 57 funds tracked by Wall St. Rank hold VANI as of Q2 2016.

Jefferies Group reported no remaining Vivani Medical position as of Q2 2016 after selling out during the quarter.
Jefferies Group sold 1,042 Vivani Medical shares in Q2 2016, an estimated $121K.
Jefferies Group first reported a position in Vivani Medical in Q1 2016 and held it in 1 quarter.
Jefferies Group's Vivani Medical position peaked at $121K in Q1 2016.
57 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2016.

Based on Jefferies Group's 13F filing for Q2 2016, filed 12 Aug 2016.